Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Omega Therapeutics Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research August 14, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress August 06, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors June 24, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics To Participate In Two Upcoming Investor Conferences May 30, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer May 29, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers May 08, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress May 06, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting April 23, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control April 09, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update March 28, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024 March 06, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference December 04, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference November 20, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis November 13, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress November 09, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Participate in The Jefferies London Healthcare Conference November 07, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic Controller October 31, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC October 16, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023 October 11, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics October 04, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial September 26, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26 September 25, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Participate in Two Upcoming Investor Conferences September 21, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Announces Updates to its Board of Directors August 29, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress August 03, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Appoints Chris Schade to its Board of Directors July 12, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics to Participate in Two Upcoming Investor Conferences June 01, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Presents New Preclinical Data Demonstrating the Potential of Omega Epigenomic Controllers™ to Synergize with Immunotherapies at the ASCO 2023 Annual Meeting May 31, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress May 04, 2023 From Omega Therapeutics Via GlobeNewswire Tickers OMGA Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.